{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:23:32Z","timestamp":1792225412441,"version":"4.4.0"},"reference-count":283,"publisher":"Tech Science Press","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2025.067126","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:10:26Z","timestamp":1757319026000},"page":"2741-2785","source":"Crossref","is-referenced-by-count":19,"title":["Cancer 3D Models: Essential Tools for Understanding and Overcoming Drug Resistance"],"prefix":"10.32604","volume":"33","author":[{"given":"Sofija","family":"Jovanovi\u0107 Stojanov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Grozdani\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mila","family":"Ljuji\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Dragi\u010devi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miodrag","family":"Dragoj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Dini\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","article-title":"Cancer treatments: past, present, and future","volume":"286\u2013287","author":"Sonkin","year":"2024","journal-title":"Cancer Genet"},{"key":"ref4","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resistance"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/ddc3020024","article-title":"Two-dimensional and spheroid-based three-dimensional cell culture systems: implications for drug discovery in cancer","volume":"3","author":"Garnique","year":"2024","journal-title":"Drugs Drug Candidates"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"12200","DOI":"10.3390\/ijms222212200","article-title":"3D cell culture systems: tumor application, advantages, and disadvantages","volume":"22","author":"Habanjar","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"961637","DOI":"10.3389\/fonc.2022.961637","article-title":"Role of hypoxia in the tumor microenvironment and targeted therapy","volume":"12","author":"Chen","year":"2022","journal-title":"Front Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13046-020-01583-1","volume":"39","author":"Bhattacharya","year":"2020","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/bit.26845","volume":"116","author":"Nunes","year":"2019","journal-title":"Biotechnol Bioeng"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/cancers12051304","volume":"12","author":"Amaral","year":"2020","journal-title":"Cancers"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"6806","DOI":"10.3390\/ijms21186806","volume":"21","author":"Fontana","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s12276-024-01272-5","article-title":"Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology","volume":"56","author":"Thorel","year":"2024","journal-title":"Exp Mol Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s43556-023-00165-9","article-title":"Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine","volume":"5","author":"Qu","year":"2024","journal-title":"Mol Biomed"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3390\/life14091142","article-title":"Cancer patient-derived cell-based models: applications and challenges in functional precision medicine","volume":"14","author":"Dinic","year":"2024","journal-title":"Life"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3390\/cancers14041013","volume":"14","author":"Vitale","year":"2022","journal-title":"Cancers"},{"key":"ref16","first-page":"117","article-title":"The biomimetic extracellular matrix: a therapeutic tool for breast cancer research","volume":"247","author":"Tamayo-Angorrilla","year":"2022","journal-title":"Transl Res J Lab Clin Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/gels10070437","article-title":"Biomimetic hydrogel strategies for cancer therapy","volume":"10","author":"Alshehri","year":"2024","journal-title":"Gels"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1039\/C9LC00270G","article-title":"Tumor-on-a-chip: a microfluidic model to study cell response to environmental gradients","volume":"19","author":"Ayuso","year":"2019","journal-title":"Lab Chip"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"113798","DOI":"10.1016\/j.addr.2021.05.008","article-title":"Tumor-on-chip modeling of organ-specific cancer and metastasis","volume":"175","author":"Del Piccolo","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1039\/D0LC01305F","article-title":"Microfluidic technologies for immunotherapy studies on solid tumours","volume":"21","author":"Paterson","year":"2021","journal-title":"Lab Chip"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1032975","DOI":"10.3389\/fphar.2022.1032975","article-title":"Establishment and large-scale validation of a three-dimensional tumor model on an array chip for anticancer drug evaluation","volume":"13","author":"Xiao","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1021966","DOI":"10.3389\/fbioe.2022.1021966","article-title":"Advances in the application of 3D tumor models in precision oncology and drug screening","volume":"10","author":"Guan","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.3390\/cancers15174352","article-title":"Challenges and prospects of patient-derived xenografts for cancer research","volume":"15","author":"Jin","year":"2023","journal-title":"Cancers"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.actbio.2021.04.041","article-title":"Personalized models of heterogeneous 3D epithelial tumor microenvironments: ovarian cancer as a model","volume":"132","author":"Horst","year":"2021","journal-title":"Acta Biomater"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12672-023-00758-4","article-title":"A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov","volume":"14","author":"Yang","year":"2023","journal-title":"Discover Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.3390\/cancers16132478","article-title":"Emerging therapeutic strategies to overcome drug resistance in cancer cells","volume":"16","author":"Garg","year":"2024","journal-title":"Cancers"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"788","DOI":"10.20517\/cdr.2023.93","article-title":"Emerging roles of 3D-culture systems in tackling tumor drug resistance","volume":"6","author":"Nikdouz","year":"2023","journal-title":"Cancer Drug Resist"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e0291942","DOI":"10.1371\/journal.pone.0291942","article-title":"Investigation of evolutionary dynamics for drug resistance in 3D spheroid model system using cellular barcoding technology","volume":"18","author":"Yalcin","year":"2023","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1162905","DOI":"10.3389\/fimmu.2023.1162905","article-title":"Opportunities and challenges to engineer 3D models of tumor-adaptive immune interactions","volume":"14","author":"Visalakshan","year":"2023","journal-title":"Front Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"122408","DOI":"10.1016\/j.biomaterials.2023.122408","article-title":"A comprehensive review on 3D tissue models: biofabrication technologies and preclinical applications","volume":"304","author":"Xie","year":"2024","journal-title":"Biomaterials"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"061502","DOI":"10.1063\/5.0159800","article-title":"Vascularized microfluidic models of major organ structures and cancerous tissues","volume":"17","author":"Rama Varma","year":"2023","journal-title":"Biomicrofluidics"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nrc2344","article-title":"Hypoxia, DNA repair and genetic instability","volume":"8","author":"Bristow","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s42255-019-0045-8","article-title":"Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy","volume":"1","author":"Ye","year":"2019","journal-title":"Nat Metab"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/sj.bjc.6690273","article-title":"Quantification of longitudinal tissue pO2 gradients in window chamber tumours: impact on tumour hypoxia","volume":"79","author":"Dewhirst","year":"1999","journal-title":"Br J Cancer"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-022-01080-1","article-title":"Hypoxia signaling in human health and diseases: implications and prospects for therapeutics","volume":"7","author":"Luo","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrc3726","article-title":"Hypoxia and the extracellular matrix: drivers of tumour metastasis","volume":"14","author":"Gilkes","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bbamcr.2015.05.036","article-title":"The hypoxic tumor microenvironment: a driving force for breast cancer progression","volume":"1863","author":"Semenza","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/biom9080339","article-title":"Acute vs. chronic vs. cyclic hypoxia: their differential dynamics, molecular mechanisms, and effects on tumor progression","volume":"9","author":"Saxena","year":"2019","journal-title":"Biomolecules"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1056\/NEJMra1011165","article-title":"Oxygen sensing, homeostasis, and disease","volume":"365","author":"Semenza","year":"2011","journal-title":"New Engl J Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1370800","DOI":"10.3389\/fimmu.2024.1370800","article-title":"Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment","volume":"15","author":"Zhi","year":"2024","journal-title":"Front Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/cells14090673","article-title":"The distinct role of HIF-1\u03b1 and HIF-2\u03b1 in hypoxia and angiogenesis","volume":"14","author":"Bakleh","year":"2025","journal-title":"Cells"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"10246","DOI":"10.1038\/s41598-019-46763-y","article-title":"Acute and chronic hypoxia differentially predispose lungs for metastases","volume":"9","author":"Reiterer","year":"2019","journal-title":"Sci Rep"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/bcr2452","article-title":"Hypoxia-inducible factor-1\u03b1 and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients","volume":"11","author":"Kallergi","year":"2009","journal-title":"Breast Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"8416","DOI":"10.1038\/s41467-024-51995-2","volume":"15","author":"Godet","year":"2024","journal-title":"Nat Commun"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/978-1-0716-2914-7_17","article-title":"Spheroids as a 3D model of the hypoxic tumor microenvironment","volume":"2614","author":"Kirsh","year":"2023","journal-title":"Methods Mol Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3892\/or.2015.3767","article-title":"Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer","volume":"33","author":"Imamura","year":"2015","journal-title":"Oncol Rep"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13287-024-03880-4","article-title":"Tumoroids, a valid preclinical screening platform for monitoring cancer angiogenesis","volume":"15","author":"Abbasi-Malati","year":"2024","journal-title":"Stem Cell Res Therapy"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"9751","DOI":"10.1038\/s41598-025-92037-1","article-title":"Influence of experimental variables on spheroid attributes","volume":"15","author":"Zhu","year":"2025","journal-title":"Sci Rep"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol Cell Biol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbrc.2003.10.153","article-title":"RNA interference for HIF-1alpha inhibits its downstream signalling and affects cellular proliferation","volume":"312","author":"Hanze","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"e0240833","DOI":"10.1371\/journal.pone.0240833","article-title":"Comparison of VEGF-A secretion from tumor cells under cellular stresses in conventional monolayer culture and microfluidic three-dimensional spheroid models","volume":"15","author":"Sarkar","year":"2020","journal-title":"PLoS One"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3892\/ol.2022.13435","article-title":"VEGF-mediated tumour growth and EMT in 2D and 3D cell culture models of hepatocellular carcinoma","volume":"24","author":"Rawal","year":"2022","journal-title":"Oncol Lett"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1002\/adhm.201600644","article-title":"Engineered breast cancer cell spheroids reproduce biologic properties of solid tumors","volume":"5","author":"Ham","year":"2016","journal-title":"Adv Healthc Mater"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.18632\/oncotarget.13857","article-title":"Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment","volume":"8","author":"Daster","year":"2017","journal-title":"Oncotarget"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2100078","DOI":"10.1002\/anbr.202100078","article-title":"3D high-content culturing and drug screening platform to study vascularized hepatocellular carcinoma in hypoxic condition","volume":"1","author":"Lim","year":"2021","journal-title":"Adv NanoBiomed Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41420-020-00311-0","article-title":"Inside the hypoxic tumour: reprogramming of the DDR and radioresistance","volume":"6","author":"Begg","year":"2020","journal-title":"Cell Death Discov"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2041-9414-4-5","article-title":"Tumor hypoxia as a driving force in genetic instability","volume":"4","author":"Luoto","year":"2013","journal-title":"Genome Integr"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41588-018-0318-2","article-title":"Molecular landmarks of tumor hypoxia across cancer types","volume":"51","author":"Bhandari","year":"2019","journal-title":"Nat Genet"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/HP.S93413","article-title":"The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy","volume":"3","author":"Muz","year":"2015","journal-title":"Hypoxia"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41573-022-00558-5","article-title":"Targeting replication stress in cancer therapy","volume":"22","author":"da Costa","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-025-07435-0","article-title":"Targeting Chk1 and Wee1 kinases enhances radiosensitivity of 2D and 3D head and neck cancer models to X-rays and low\/high-LET protons","volume":"16","author":"Melia","year":"2025","journal-title":"Cell Death Dis"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/acsptsci.2c00200","article-title":"A scalable 3D high-content imaging protocol for measuring a drug induced DNA damage response using immunofluorescent subnuclear gammaH2AX spots in patient derived ovarian cancer organoids","volume":"6","author":"Keles","year":"2023","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.1038\/s41598-024-59001-x","article-title":"Selective impact of ALK and MELK inhibition on ERalpha stability and cell proliferation in cell lines representing distinct molecular phenotypes of breast cancer","volume":"14","author":"Bartoloni","year":"2024","journal-title":"Sci Rep"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3892\/ol.2013.1321","article-title":"Expression and significance of hypoxia-inducible factor-1alpha and MDR1\/P-glycoprotein in laryngeal carcinoma tissue and hypoxic Hep-2 cells","volume":"6","author":"Xie","year":"2013","journal-title":"Oncol Lett"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s10072-014-1681-0","article-title":"Expression of HIF-1alpha and MDR1\/P-glycoprotein in refractory mesial temporal lobe epilepsy patients and pharmacoresistant temporal lobe epilepsy rat model kindled by coriaria lactone","volume":"35","author":"Li","year":"2014","journal-title":"Neurol Sci"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"e98882","DOI":"10.1371\/journal.pone.0098882","article-title":"HIF-1\u03b1 inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1\/P-glycoprotein","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"ref69","first-page":"1629","article-title":"Effect of hypoxia on HIF-1\u03b1\/MDR1\/VEGF expression in gastric cancer cells treated with 5-fluorouracil","volume":"47","author":"Wang","year":"2022","journal-title":"J Cent South Univ Med Sci"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"14655","DOI":"10.1021\/acs.jmedchem.2c01175","article-title":"New dual p-glycoprotein (P-gp) and human carbonic anhydrase XII (hCA XII) inhibitors as multidrug resistance (MDR) reversers in cancer cells","volume":"65","author":"Braconi","year":"2022","journal-title":"J Med Chem"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"117577","DOI":"10.1016\/j.biopha.2024.117577","article-title":"Developing a novel P-glycoprotein inhibitor and pairing it with oral paclitaxel liposomes for enhanced cancer therapy","volume":"180","author":"Deng","year":"2024","journal-title":"Biomed Pharmacotherapy"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/brainsci11081025","article-title":"Development and validation of a long-term 3D glioblastoma cell culture in alginate microfibers as a novel bio-mimicking model system for preclinical drug testing","volume":"11","author":"Dragoj","year":"2021","journal-title":"Brain Sci"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"45745","DOI":"10.18632\/oncotarget.9935","article-title":"The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance","volume":"7","author":"Breslin","year":"2016","journal-title":"Oncotarget"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"20066","DOI":"10.1038\/s41598-019-56273-6","article-title":"Dissecting multi drug resistance in head and neck cancer cells using multicellular tumor spheroids","volume":"9","author":"Azharuddin","year":"2019","journal-title":"Sci Rep"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/aps.2015.92","article-title":"Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment","volume":"36","author":"Sun","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"e2003897","DOI":"10.1002\/advs.202003897","article-title":"Single-cell transcriptome analysis uncovers intratumoral heterogeneity and underlying mechanisms for drug resistance in hepatobiliary tumor organoids","volume":"8","author":"Zhao","year":"2021","journal-title":"Adv Sci"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"eadc8933","DOI":"10.1126\/sciadv.adc8933","article-title":"Single-cell RNA sequencing highlights intratumor heterogeneity and intercellular network featured in adamantinomatous craniopharyngioma","volume":"9","author":"Jiang","year":"2023","journal-title":"Sci Adv"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"216610","DOI":"10.1016\/j.canlet.2024.216610","article-title":"Advanced insights on tumor-associated macrophages revealed by single-cell RNA sequencing: the intratumor heterogeneity, functional phenotypes, and cellular interactions","volume":"584","author":"Yang","year":"2024","journal-title":"Cancer Lett"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.biotechadv.2016.11.002","article-title":"3D tumor spheroids: an overview on the tools and techniques used for their analysis","volume":"34","author":"Costa","year":"2016","journal-title":"Biotechnol Adv"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1310397","DOI":"10.3389\/fcell.2023.1310397","article-title":"Doxorubicin-sensitive and -resistant colorectal cancer spheroid models: assessing tumor microenvironment features for therapeutic modulation","volume":"11","author":"Valente","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s44164-023-00059-8","article-title":"3D tumor spheroids: morphological alterations a yardstick to anti-cancer drug response","volume":"2","author":"Senrung","year":"2023","journal-title":"In Vitro Models"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-3-030-58174-9_11","volume":"1295","author":"Daunys","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"8430","DOI":"10.1016\/j.biomaterials.2012.08.040","article-title":"An oxygen-permeable spheroid culture system for the prevention of central hypoxia and necrosis of spheroids","volume":"33","author":"Anada","year":"2012","journal-title":"Biomaterials"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fmolb.2020.00033","article-title":"Is it time to start transitioning from 2D to 3D cell culture?","volume":"7","author":"Jensen","year":"2020","journal-title":"Front Mol Biosci"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.cell.2020.08.043","article-title":"Multimodal analysis of composition and spatial architecture in human squamous cell carcinoma","volume":"182","author":"Ji","year":"2020","journal-title":"Cell"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-022-05425-2","article-title":"Spatial genomics maps the structure, nature and evolution of cancer clones","volume":"611","author":"Lomakin","year":"2022","journal-title":"Nature"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ccell.2022.05.009","article-title":"Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma","volume":"40","author":"Ravi","year":"2022","journal-title":"Cancer Cell"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41592-023-02126-0","article-title":"Smart lattice light-sheet microscopy for imaging rare and complex cellular events","volume":"21","author":"Shi","year":"2024","journal-title":"Nat Methods"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41597-025-04832-0","article-title":"Single-cell light-sheet fluorescence 3D images of tumour-stroma spheroid multicultures","volume":"12","author":"Diosdi","year":"2025","journal-title":"Sci Data"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrc1893","article-title":"Drug penetration in solid tumours","volume":"6","author":"Minchinton","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"e72532","DOI":"10.1371\/journal.pone.0072532","article-title":"Determination of paclitaxel distribution in solid tumors by nano-particle assisted laser desorption ionization mass spectrometry imaging","volume":"8","author":"Morosi","year":"2013","journal-title":"PLoS One"},{"key":"ref93","first-page":"181","article-title":"Multifactorial nature of tumor drug resistance","volume":"32","author":"Solyanik","year":"2010","journal-title":"Exp Oncol"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PPO.0000000000000138","article-title":"The contribution of angiogenesis to the process of metastasis","volume":"21","author":"Bielenberg","year":"2015","journal-title":"Cancer J"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"e2403253","DOI":"10.1002\/advs.202403253","article-title":"Fluorescence lifetime imaging for quantification of targeted drug delivery in varying tumor microenvironments","volume":"12","author":"Verma","year":"2025","journal-title":"Adv Sci"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1158\/0008-5472.CAN-19-0638","article-title":"Localized metabolomic gradients in patient-derived xenograft models of glioblastoma","volume":"80","author":"Randall","year":"2020","journal-title":"Cancer Res"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"37027","DOI":"10.1038\/srep37027","article-title":"3D mass spectrometry imaging reveals a very heterogeneous drug distribution in tumors","volume":"6","author":"Giordano","year":"2016","journal-title":"Sci Rep"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.1021\/ac400519c","article-title":"Evaluation of therapeutics in three-dimensional cell culture systems by MALDI imaging mass spectrometry","volume":"85","author":"Liu","year":"2013","journal-title":"Anal Chem"},{"key":"ref99","first-page":"64","article-title":"Multimodal platform for assessing drug distribution and response in clinical trials","volume":"24","author":"Lopez","year":"2022","journal-title":"Neurooncol"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1038\/s41467-024-48010-z","article-title":"A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by light sheet fluorescence microscopy","volume":"15","author":"Ascheid","year":"2024","journal-title":"Nat Commun"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/cpt.1211","article-title":"Tumor drug penetration measurements could be the neglected piece of the personalized cancer treatment puzzle","volume":"106","author":"Bartelink","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.jtho.2021.07.017","article-title":"Mechanism of drug tolerant persister cancer cells: the landscape and clinical implication for therapy","volume":"16","author":"Mikubo","year":"2021","journal-title":"J Thorac Oncol"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ccell.2019.12.006","article-title":"Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway","volume":"37","author":"Kurppa","year":"2020","journal-title":"Cancer Cell"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/cancers13051118","article-title":"Fighting drug resistance through the targeting of drug-tolerant persister cells","volume":"13","author":"De Conti","year":"2021","journal-title":"Cancers"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbcan.2018.10.003","article-title":"EMT: a mechanism for escape from EGFR-targeted therapy in lung cancer","volume":"1871","author":"Tulchinsky","year":"2019","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014Rev Cancer"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1158\/2159-8290.CD-17-0461","article-title":"Suppression of adaptive responses to targeted cancer therapy by transcriptional repression","volume":"8","author":"Rusan","year":"2018","journal-title":"Cancer Discov"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1158\/0008-5472.CAN-17-1904","article-title":"ER stress signaling promotes the survival of cancer persister cells tolerant to EGFR tyrosine kinase inhibitors","volume":"78","author":"Terai","year":"2018","journal-title":"Cancer Res"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"e000362","DOI":"10.1136\/bmjonc-2024-000362","article-title":"Integrated multiplex analysis of cell death regulators in stage II colorectal cancer suggests patients with \u2018persister\u2019 cell profiles fail to benefit from adjuvant chemotherapy","volume":"3","author":"Cho","year":"2024","journal-title":"BMJ Oncol"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"lnae040","DOI":"10.1093\/lifemedi\/lnae040","article-title":"Metabolic orchestration of drug-tolerant persister cells in cancer","volume":"3","author":"Nie","year":"2024","journal-title":"Life Med"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"e135038","DOI":"10.1172\/JCI135038","article-title":"Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade","volume":"131","author":"Sehgal","year":"2021","journal-title":"J Clin Investig"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1158\/0008-5472.CAN-21-2908","article-title":"Sustained oncogenic signaling in the cytostatic state enables targeting of nonproliferating persistent cancer cells","volume":"82","author":"Kim","year":"2022","journal-title":"Cancer Res"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.stem.2018.12.009","article-title":"Cancer stem cells: the architects of the tumor ecosystem","volume":"24","author":"Prager","year":"2019","journal-title":"Cell Stem Cell"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","article-title":"Cancer stem cells: advances in knowledge and implications for cancer therapy","volume":"9","author":"Chu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.stem.2015.02.015","article-title":"The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?","volume":"16","author":"Plaks","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1158\/0008-5472.CAN-05-0626","volume":"65","author":"Ponti","year":"2005","journal-title":"Cancer Res"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1634\/stemcells.2006-0624","article-title":"Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells","volume":"25","author":"Ghods","year":"2007","journal-title":"Stem Cells"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"e16466","DOI":"10.1371\/journal.pone.0016466","article-title":"Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1038\/s41598-025-90689-7","article-title":"Diversity of ER-positive and HER2-negative breast cancer stem cells attained using selective culture techniques","volume":"15","author":"Sueoka","year":"2025","journal-title":"Sci Rep"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1038\/s41598-025-87054-z","article-title":"Patient-derived xenografts from circulating cancer stem cells as a preclinical model for personalized pancreatic cancer research","volume":"15","author":"Wagner","year":"2025","journal-title":"Sci Rep"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.3390\/ijms232113306","article-title":"Comparison of EMT-related and multi-drug resistant gene expression, extracellular matrix production, and drug sensitivity in NSCLC spheroids generated by scaffold-free and scaffold-based methods","volume":"23","author":"Qi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-020-00931-0","article-title":"Modeling neoplastic disease with spheroids and organoids","volume":"13","author":"Zanoni","year":"2020","journal-title":"J Hematol Oncol"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00018-023-05099-7","article-title":"Wnt\/\u03b2-catenin-driven EMT regulation in human cancers","volume":"81","author":"Xue","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1158\/1541-7786.MCR-20-0067","article-title":"Epithelial-mesenchymal transition programs and cancer stem cell phenotypes: mediators of breast cancer therapy resistance","volume":"18","author":"Gooding","year":"2020","journal-title":"Mol Cancer Res: MCR"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.3892\/mmr.2015.3694","article-title":"Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor","volume":"12","author":"Huang","year":"2015","journal-title":"Mol Med Rep"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nm.2379","article-title":"Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs","volume":"17","author":"Oskarsson","year":"2011","journal-title":"Nat Med"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1158\/0008-5472.CAN-16-2171","article-title":"Activation of NOTCH signaling by tenascin-C promotes growth of human brain tumor-initiating cells","volume":"77","author":"Sarkar","year":"2017","journal-title":"Cancer Res"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"jcs256461","DOI":"10.1242\/jcs.256461","article-title":"A three-dimensional spheroid-specific role for Wnt-beta-catenin and Eph-ephrin signaling in nasopharyngeal carcinoma cells","volume":"134","author":"Yi","year":"2021","journal-title":"J Cell Sci"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s40425-019-0666-1","article-title":"Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments","volume":"7","author":"Raghavan","year":"2019","journal-title":"J Immunother Cancer"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.3390\/ijms20143568","article-title":"Cell type-specific TGF-beta mediated EMT in 3D and 2D models and its reversal by TGF-beta receptor kinase inhibitor in ovarian cancer cell lines","volume":"20","author":"Al Ameri","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1039\/D3LC00886J","article-title":"Interstitial flow potentiates TGF-beta\/Smad-signaling activity in lung cancer spheroids in a 3D-microfluidic chip","volume":"24","author":"Rahman","year":"2024","journal-title":"Lab Chip"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"5416923","DOI":"10.1155\/2018\/5416923","article-title":"Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment","volume":"2018","author":"Phi","year":"2018","journal-title":"Stem Cells Int"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/acsptsci.1c00257","article-title":"Therapeutic targeting of cancer stem cells prevents resistance of colorectal cancer cells to MEK inhibition","volume":"5","author":"Lamichhane","year":"2022","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.7150\/thno.24003","article-title":"OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma","volume":"8","author":"Qi","year":"2018","journal-title":"Theranostics"},{"key":"ref135","doi-asserted-by":"crossref","first-page":"10357","DOI":"10.1038\/srep10357","volume":"5","author":"Cioffi","year":"2015","journal-title":"Sci Rep"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jcb.26298","article-title":"Breast cancer stem cells are involved in Trastuzumab resistance through the HER2 modulation in 3D culture","volume":"119","author":"Rodriguez","year":"2018","journal-title":"J Cell Biochem"},{"key":"ref137","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12195-024-00798-y","article-title":"Three-dimensional tumor models to study cancer stemness-mediated drug resistance","volume":"17","author":"Lamichhane","year":"2024","journal-title":"Cell Mol Bioeng"},{"key":"ref138","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","volume":"7","author":"Pauli","year":"2017","journal-title":"Cancer Discov"},{"key":"ref139","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.7150\/thno.28745","article-title":"Microfluidic isolation of circulating tumor cells and cancer stem-like cells from patients with pancreatic ductal adenocarcinoma","volume":"9","author":"Varillas","year":"2019","journal-title":"Theranostics"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jbiotec.2014.11.008","article-title":"A 3D tension bioreactor platform to study the interplay between ECM stiffness and tumor phenotype","volume":"193","author":"Cassereau","year":"2015","journal-title":"J Biotechnol"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"119705","DOI":"10.1016\/j.biomaterials.2019.119705","article-title":"Patient-derived scaffolds uncover breast cancer promoting properties of the microenvironment","volume":"235","author":"Landberg","year":"2020","journal-title":"Biomaterials"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"1339251","DOI":"10.3389\/fcell.2024.1339251","article-title":"The role of cell-matrix adhesion and cell migration in breast tumor growth and progression","volume":"12","author":"Chong","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"ref143","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3390\/cancers11050692","article-title":"Role of integrins in resistance to therapies targeting growth factor receptors in cancer","volume":"11","author":"da Silva E","year":"2019","journal-title":"Cancers"},{"key":"ref144","first-page":"101686","article-title":"Blockage of alphavbeta3 integrin in 3D culture of triple-negative breast cancer and endothelial cells inhibits migration and discourages endothelial-to-mesenchymal plasticity","volume":"38","author":"Casali","year":"2024","journal-title":"Biochem Biophys Rep"},{"key":"ref145","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.biomaterials.2015.09.007","article-title":"Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells","volume":"73","author":"Tian","year":"2015","journal-title":"Biomaterials"},{"key":"ref146","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/s41388-020-01492-9","article-title":"Molecular biological analysis of 5-FU-resistant gastric cancer organoids; KHDRBS3 contributes to the attainment of features of cancer stem cell","volume":"39","author":"Ukai","year":"2020","journal-title":"Oncogene"},{"key":"ref147","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","article-title":"Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments","volume":"22","author":"Yuan","year":"2023","journal-title":"Mol Cancer"},{"key":"ref148","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1186\/s12935-020-01718-6","volume":"20","author":"Magan","year":"2020","journal-title":"Cancer Cell Int"},{"key":"ref149","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12964-019-0505-5","article-title":"Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis","volume":"18","author":"Neuwirt","year":"2020","journal-title":"Cell Commun Signal"},{"key":"ref150","doi-asserted-by":"crossref","first-page":"e0127948","DOI":"10.1371\/journal.pone.0127948","article-title":"Fibroblasts influence survival and therapeutic response in a 3D co-culture model","volume":"10","author":"Majety","year":"2015","journal-title":"PLoS One"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.canlet.2021.03.021","article-title":"Cancer-associated fibroblasts activated by miR-196a promote the migration and invasion of lung cancer cells","volume":"508","author":"Lee","year":"2021","journal-title":"Cancer Lett"},{"key":"ref152","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcmgh.2020.09.003","article-title":"Cancer-associated fibroblasts provide a stromal niche for liver cancer organoids that confers trophic effects and therapy resistance","volume":"11","author":"Liu","year":"2021","journal-title":"Cellular Mol Gastroenterol Hepatol"},{"key":"ref153","first-page":"258","article-title":"Protein- and growth-modulatory effects of carcinoma-associated fibroblasts on breast cancer cells: role of interleukin-6","volume":"56","author":"Dittmer","year":"2020","journal-title":"Int J Oncol"},{"key":"ref154","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-021-03651-8","article-title":"Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells","volume":"595","author":"Casanova-Acebes","year":"2021","journal-title":"Nature"},{"key":"ref155","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.imbio.2010.05.019","article-title":"Importance of CCL2-CCR2A\/2B signaling for monocyte migration into spheroids of breast cancer-derived fibroblasts","volume":"215","author":"Ksiazkiewicz","year":"2010","journal-title":"Immunobiology"},{"key":"ref156","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1021\/cr9000226","article-title":"ABC efflux pump-based resistance to chemotherapy drugs","volume":"109","author":"Eckford","year":"2009","journal-title":"Chem Rev"},{"key":"ref157","doi-asserted-by":"crossref","first-page":"25956","DOI":"10.1038\/srep25956","article-title":"ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells","volume":"6","author":"Wee","year":"2016","journal-title":"Sci Rep"},{"key":"ref158","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3892\/etm.2022.11658","article-title":"ABCG2, CD44 and SOX9 are increased with the acquisition of drug resistance and involved in cancer stem cell activities in head and neck squamous cell carcinoma cells","volume":"24","author":"Murakami","year":"2022","journal-title":"Exp Ther Med"},{"key":"ref159","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/hed.23820","article-title":"Regulation of tumor progression via the Snail-RKIP signaling pathway by nicotine exposure in head and neck squamous cell carcinoma","volume":"37","author":"Nieh","year":"2015","journal-title":"Head Neck"},{"key":"ref160","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1158\/1535-7163.MCT-15-0050","article-title":"Inhibition of ABCB1 overcomes cancer stem cell-like properties and acquired resistance to MET inhibitors in non-small cell lung cancer","volume":"14","author":"Sugano","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"e0155013","DOI":"10.1371\/journal.pone.0155013","article-title":"Role of the drug transporter ABCC3 in breast cancer chemoresistance","volume":"11","author":"Balaji","year":"2016","journal-title":"PLoS One"},{"key":"ref162","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40170-022-00285-w","article-title":"Metabolic flux analysis of 3D spheroids reveals significant differences in glucose metabolism from matched 2D cultures of colorectal cancer and pancreatic ductal adenocarcinoma cell lines","volume":"10","author":"Tidwell","year":"2022","journal-title":"Cancer Metab"},{"key":"ref163","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2407-13-95","article-title":"3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing","volume":"13","author":"Longati","year":"2013","journal-title":"BMC Cancer"},{"key":"ref164","doi-asserted-by":"crossref","first-page":"15267","DOI":"10.1038\/ncomms15267","article-title":"Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells","volume":"8","author":"Elia","year":"2017","journal-title":"Nat Commun"},{"key":"ref165","doi-asserted-by":"crossref","first-page":"e106973","DOI":"10.1371\/journal.pone.0106973","article-title":"The cultural divide: exponential growth in classical 2D and metabolic equilibrium in 3D environments","volume":"9","author":"Wrzesinski","year":"2014","journal-title":"PLoS One"},{"key":"ref166","doi-asserted-by":"crossref","first-page":"101162","DOI":"10.1016\/j.xcrm.2023.101162","article-title":"Metabolic classification suggests the GLUT1\/ALDOB\/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer","volume":"4","author":"Li","year":"2023","journal-title":"Cell Rep Med"},{"key":"ref167","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ebiom.2018.10.046","article-title":"Organotypic microfluidic breast cancer model reveals starvation-induced spatial-temporal metabolic adaptations","volume":"37","author":"Ayuso","year":"2018","journal-title":"EBioMedicine"},{"key":"ref168","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/mi9030094","article-title":"Prediction of necrotic core and hypoxic zone of multicellular spheroids in a microbioreactor with a u-shaped barrier","volume":"9","author":"Barisam","year":"2018","journal-title":"Micromachines"},{"key":"ref169","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/biology13090724","volume":"13","author":"Martinez-Bernabe","year":"2024","journal-title":"Biology"},{"key":"ref170","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/cbf.3890","article-title":"Transcript CD81-215 may be a long noncoding RNA of stromal origin with tumor-promoting role in colon cancer","volume":"41","author":"Jovanovic","year":"2023","journal-title":"Cell Biochem Funct"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.7150\/jca.98911","article-title":"Dysregulation of transcripts SMAD4-209 and SMAD4-213 and their respective promoters in colon cancer cell lines","volume":"15","author":"Babic","year":"2024","journal-title":"J Cancer"},{"key":"ref172","doi-asserted-by":"crossref","first-page":"111536","DOI":"10.1016\/j.biopha.2021.111536","volume":"138","author":"Nowacka","year":"2021","journal-title":"Biomed Pharmacotherapy"},{"key":"ref173","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1038\/s41598-019-43090-0","article-title":"Characterization of the physical properties of tumor-derived spheroids reveals critical insights for pre-clinical studies","volume":"9","author":"Guillaume","year":"2019","journal-title":"Sci Rep"},{"key":"ref174","doi-asserted-by":"crossref","first-page":"21273","DOI":"10.1038\/s41598-020-78087-7","article-title":"Advanced co-culture 3D breast cancer model for investigation of fibrosis induced by external stimuli: optimization study","volume":"10","author":"Yakavets","year":"2020","journal-title":"Sci Rep"},{"key":"ref175","doi-asserted-by":"crossref","first-page":"10394","DOI":"10.1038\/s41598-023-37311-w","article-title":"Macrophage induces anti-cancer drug resistance in canine mammary gland tumor spheroid","volume":"13","author":"Lim","year":"2023","journal-title":"Sci Rep"},{"key":"ref176","doi-asserted-by":"crossref","first-page":"11574","DOI":"10.1038\/s41598-020-68441-0","article-title":"High-throughput screening reveals higher synergistic effect of MEK inhibitor combinations in colon cancer spheroids","volume":"10","author":"Folkesson","year":"2020","journal-title":"Sci Rep"},{"key":"ref177","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3390\/cancers12061590","article-title":"Preclinical evaluation of the novel small-molecule MSI-N1014 for treating drug-resistant colon cancer via the LGR5\/\u03b2-catenin\/miR-142-3p network and reducing cancer-associated fibroblast transformation","volume":"12","author":"Yadav","year":"2020","journal-title":"Cancers"},{"key":"ref178","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/1878-0261.13502","article-title":"High-content screening of drug combinations of an mPGES-1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistance","volume":"18","author":"Zaghmi","year":"2024","journal-title":"Mol Oncol"},{"key":"ref179","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.3390\/cancers13153821","article-title":"A novel ZIP4-HDAC4-VEGFA axis in high-grade serous ovarian cancer","volume":"13","author":"Fan","year":"2021","journal-title":"Cancers"},{"key":"ref180","doi-asserted-by":"crossref","first-page":"121018","DOI":"10.1016\/j.ijpharm.2021.121018","article-title":"Hypoxia-targeted cupric-tirapazamine liposomes potentiate radiotherapy in prostate cancer spheroids","volume":"607","author":"Silva","year":"2021","journal-title":"Int J Pharm"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3390\/pharmaceutics12121186","volume":"12","author":"Pinto","year":"2020","journal-title":"Pharmaceutics"},{"key":"ref182","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/cells12071001","article-title":"Cancer spheroids and organoids as novel tools for research and therapy: state of the art and challenges to guide precision medicine","volume":"12","author":"El Harane","year":"2023","journal-title":"Cells"},{"key":"ref183","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1016\/j.cell.2021.09.022","article-title":"Spatially confined sub-tumor microenvironments in pancreatic cancer","volume":"184","author":"Grunwald","year":"2021","journal-title":"Cell"},{"key":"ref184","doi-asserted-by":"crossref","first-page":"107490","DOI":"10.1016\/j.phrs.2024.107490","article-title":"GSTA1\/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular carcinoma","volume":"210","author":"Ma","year":"2024","journal-title":"Pharmacol Res"},{"key":"ref185","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3390\/genes15121624","article-title":"The impact of bevacizumab and miR200c on EMT and EGFR-TKI resistance in EGFR-mutant lung cancer organoids","volume":"15","author":"Kobayashi","year":"2024","journal-title":"Genes"},{"key":"ref186","doi-asserted-by":"crossref","first-page":"eaay2574","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci Transl Med"},{"key":"ref187","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jncc.2022.10.001","article-title":"Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): new opportunities in establishing faithful pre-clinical cancer models","volume":"2","author":"Wang","year":"2022","journal-title":"J Natl Cancer Center"},{"key":"ref188","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41556-023-01194-w","article-title":"Advances and prospects for the Human BioMolecular Atlas Program (HuBMAP)","volume":"25","author":"Jain","year":"2023","journal-title":"Nat Cell Biol"},{"key":"ref189","doi-asserted-by":"crossref","first-page":"1510429","DOI":"10.3389\/fbloc.2025.1510429","article-title":"Decentralized biobanking platform for organoid research networks","volume":"8","author":"Gross","year":"2025","journal-title":"Front Blockchain"},{"key":"ref190","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1038\/s41596-020-0379-4","article-title":"Establishment of patient-derived cancer organoids for drug-screening applications","volume":"15","author":"Driehuis","year":"2020","journal-title":"Nat Protoc"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"e2204097","DOI":"10.1002\/advs.202204097","article-title":"Patient-derived organoids from colorectal cancer with paired liver metastasis reveal tumor heterogeneity and predict response to chemotherapy","volume":"9","author":"Mo","year":"2022","journal-title":"Adv Sci"},{"key":"ref192","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.21873\/invivo.13263","article-title":"Patient-derived organoid model for predicting the chemoresponse in patients with colorectal cancer","volume":"37","author":"Yi","year":"2023","journal-title":"In Vivo"},{"key":"ref193","doi-asserted-by":"crossref","first-page":"100911","DOI":"10.1016\/j.xcrm.2022.100911","article-title":"Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: a real-world study","volume":"4","author":"Wang","year":"2023","journal-title":"Cell Rep Med"},{"key":"ref194","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41392-022-01248-9","article-title":"Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression","volume":"8","author":"Tan","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"ref195","doi-asserted-by":"crossref","first-page":"217506","DOI":"10.1016\/j.canlet.2025.217506","volume":"614","author":"Scholtes","year":"2025","journal-title":"Cancer Lett"},{"key":"ref196","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/1878-0261.13725","volume":"19","author":"Tapia Contreras","year":"2025","journal-title":"Mol Oncol"},{"key":"ref197","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12935-025-03654-9","article-title":"MTMR6 downregulation contributes to cisplatin resistance in oral squamous cell carcinoma","volume":"25","author":"Lee","year":"2025","journal-title":"Cancer Cell Int"},{"key":"ref198","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.1188302","article-title":"Reconstituting organ-level lung functions on a chip","volume":"328","author":"Huh","year":"2010","journal-title":"Science"},{"key":"ref199","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3390\/cancers14040935","article-title":"Organ-on-a-chip platforms for drug screening and delivery in tumor cells: a systematic review","volume":"14","author":"Goncalves","year":"2022","journal-title":"Cancers"},{"key":"ref200","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1039\/D0LC00419G","article-title":"Controlled pharmacokinetic anti-cancer drug concentration profiles lead to growth inhibition of colorectal cancer cells in a microfluidic device","volume":"20","author":"Komen","year":"2020","journal-title":"Lab Chip"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/s41598-017-01256-8","volume":"7","author":"Beer","year":"2017","journal-title":"Sci Rep"},{"key":"ref202","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1039\/D0LC00707B","article-title":"An engineered pancreatic cancer model with intra-tumoral heterogeneity of driver mutations","volume":"20","author":"Moon","year":"2020","journal-title":"Lab Chip"},{"key":"ref203","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.3390\/ijms20184647","article-title":"Interstitial flow recapitulates gemcitabine chemoresistance in a 3D microfluidic pancreatic ductal adenocarcinoma model by induction of multidrug resistance proteins","volume":"20","author":"Kramer","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref204","doi-asserted-by":"crossref","first-page":"36670","DOI":"10.1038\/srep36670","volume":"6","author":"Xu","year":"2016","journal-title":"Sci Rep"},{"key":"ref205","doi-asserted-by":"crossref","first-page":"612091","DOI":"10.3389\/fbioe.2020.612091","article-title":"Proteomic reveals reasons for acquired drug resistance in lung cancer derived brain metastasis based on a newly established multi-organ microfluidic chip model","volume":"8","author":"Xu","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"ref206","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.actbio.2019.04.053","article-title":"AKR1B10 (Aldo-keto reductase family 1 B10) promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model","volume":"91","author":"Liu","year":"2019","journal-title":"Acta Biomater"},{"key":"ref207","doi-asserted-by":"crossref","first-page":"25840","DOI":"10.1021\/acsami.6b08746","volume":"8","author":"Xu","year":"2016","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref208","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1039\/D0LC00424C","article-title":"Integrated human organ-on-a-chip model for predictive studies of anti-tumor drug efficacy and cardiac safety","volume":"20","author":"Chramiec","year":"2020","journal-title":"Lab Chip"},{"key":"ref209","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.talanta.2018.08.016","article-title":"Near-physiological microenvironment simulation on chip to evaluate drug resistance of different loci in tumour mass","volume":"191","author":"Wang","year":"2019","journal-title":"Talanta"},{"key":"ref210","doi-asserted-by":"crossref","first-page":"119547","DOI":"10.1016\/j.biomaterials.2019.119547","article-title":"Vascularized cancer on a chip: the effect of perfusion on growth and drug delivery of tumor spheroid","volume":"229","author":"Nashimoto","year":"2020","journal-title":"Biomaterials"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1872-2040(17)61064-8","article-title":"Construction of tumor tissue array on an open-access microfluidic chip","volume":"46","author":"Lin","year":"2018","journal-title":"Chin J Anal Chem"},{"key":"ref212","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1039\/C6LC01422D","article-title":"A vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications","volume":"17","author":"Phan","year":"2017","journal-title":"Lab Chip"},{"key":"ref213","doi-asserted-by":"crossref","first-page":"106805","DOI":"10.1016\/j.ejps.2024.106805","article-title":"Evaluation of drug resistance for EGFR-TKIs in lung cancer via multicellular lung-on-a-chip","volume":"199","author":"Tan","year":"2024","journal-title":"Eur J Pharm Sci"},{"key":"ref214","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1021\/acsbiomaterials.0c00650","article-title":"Tumor-microenvironment-on-a-chip for evaluating nanoparticle-loaded macrophages for drug delivery","volume":"6","author":"Wang","year":"2020","journal-title":"ACS Biomater Sci Eng"},{"key":"ref215","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s43856-022-00209-1","article-title":"Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology","volume":"2","author":"Ewart","year":"2022","journal-title":"Commun Med"},{"key":"ref216","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1186\/s12967-025-06593-1","article-title":"Patient-derived esophageal adenocarcinoma organ chip: a physiologically relevant platform for functional precision oncology","volume":"23","author":"Pal","year":"2025","journal-title":"J Transl Med"},{"key":"ref217","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1021\/acsbiomaterials.5c00336","article-title":"Changes in generations of PAMAM dendrimers and compositions of nucleic acid nanoparticles govern delivery and immune recognition","volume":"11","author":"Avila","year":"2025","journal-title":"ACS Biomater Sci Eng"},{"key":"ref218","doi-asserted-by":"crossref","DOI":"10.1165\/rcmb.2024-0614OC","article-title":"Insights into the cellular and molecular mechanisms behind the antifibrotic effects of nerandomilast","author":"Reininger","year":"2025","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref219","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12987-018-0108-3","article-title":"A perfused human blood-brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport","volume":"15","author":"Wevers","year":"2018","journal-title":"Fluids Barriers CNS"},{"key":"ref220","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3390\/bioengineering10101195","article-title":"Reproducibility and robustness of a liver microphysiological system physioMimix LC12 under varying culture conditions and cell type combinations","volume":"10","author":"Lim","year":"2023","journal-title":"Bioengineering"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"100001","DOI":"10.1124\/dmd.124.001488","article-title":"Comparative analysis of the physiological and transport functions of various sources of renal proximal tubule cells under static and fluidic conditions in PhysioMimix T12 platform","volume":"53","author":"Sakolish","year":"2025","journal-title":"Drug Metab Disposition Biol Fate Chem"},{"key":"ref222","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3390\/cancers12051327","article-title":"Patient-derived xenograft models of pancreatic cancer: overview and comparison with other types of models","volume":"12","author":"Garcia","year":"2020","journal-title":"Cancers"},{"key":"ref223","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","article-title":"Patient-derived xenograft models in cancer therapy: technologies and applications","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"ref224","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12967-022-03405-8","article-title":"Patient-derived xenograft (PDX) models, applications and challenges in cancer research","volume":"20","author":"Abdolahi","year":"2022","journal-title":"J Transl Med"},{"key":"ref225","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/clpt.2013.117","article-title":"Clinical approval success rates for investigational cancer drugs","volume":"94","author":"DiMasi","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"ref226","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1054\/bjoc.2001.1796","volume":"84","author":"Johnson","year":"2001","journal-title":"Br J Cancer"},{"key":"ref227","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","article-title":"Patient-derived xenograft models: an emerging platform for translational cancer research","volume":"4","author":"Hidalgo","year":"2014","journal-title":"Cancer Discov"},{"key":"ref228","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.3390\/curroncol30100657","article-title":"Patient derived xenografts (PDX) models as an avatar to assess personalized therapy options in uveal melanoma: a feasibility study","volume":"30","author":"Nemati","year":"2023","journal-title":"Curr Oncol"},{"key":"ref229","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1038\/s41467-021-25177-3","article-title":"Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment","volume":"12","author":"Sun","year":"2021","journal-title":"Nat Commun"},{"key":"ref230","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/annonc\/mdx098","article-title":"Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma","volume":"28","author":"Kim","year":"2017","journal-title":"Ann Oncol"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3390\/cancers15030701","article-title":"Mechanism-driven and clinically focused development of botanical foods as multitarget anticancer medicine: collective perspectives and insights from preclinical studies, IND applications and early-phase clinical trials","volume":"15","author":"Wang","year":"2023","journal-title":"Cancers"},{"key":"ref232","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw148","article-title":"Mechanisms of therapy resistance in patient-derived xenograft models of BRCA1-deficient breast cancer","volume":"108","author":"Ter Brugge","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"ref233","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.ejca.2010.12.019","article-title":"Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: activation of MET as one mechanism for drug resistance","volume":"47","author":"Krumbach","year":"2011","journal-title":"Eur J Cancer"},{"key":"ref234","doi-asserted-by":"crossref","first-page":"640957","DOI":"10.3389\/fcell.2021.640957","article-title":"Cabozantinib reverses topotecan resistance in human non-small cell lung cancer NCI-H460\/TPT10 cell line and tumor xenograft model","volume":"9","author":"Lei","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"ref235","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1593\/neo.12538","article-title":"Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition","volume":"14","author":"Venkatesha","year":"2012","journal-title":"Neoplasia"},{"key":"ref236","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1158\/1078-0432.CCR-19-2409","article-title":"A subset of colorectal cancers with cross-sensitivity to olaparib and oxaliplatin","volume":"26","author":"Arena","year":"2020","journal-title":"Clin Cancer Res"},{"key":"ref237","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1158\/2159-8290.CD-14-1211","article-title":"HER2 activating mutations are targets for colorectal cancer treatment","volume":"5","author":"Kavuri","year":"2015","journal-title":"Cancer Discov"},{"key":"ref238","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.1038\/s41388-021-01911-5","article-title":"Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma","volume":"40","author":"Wang","year":"2021","journal-title":"Oncogene"},{"key":"ref239","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1158\/0008-5472.CAN-14-1424","article-title":"Mouse models of human cancer","volume":"74","author":"Bock","year":"2014","journal-title":"Cancer Res"},{"key":"ref240","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/cells8060605","article-title":"Development of personalized therapeutic strategies by targeting actionable vulnerabilities in metastatic and chemotherapy-resistant breast cancer PDXs","volume":"8","author":"Punzi","year":"2019","journal-title":"Cells"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12864-022-08367-1","article-title":"The EurOPDX Data Portal: an open platform for patient-derived cancer xenograft data sharing and visualization","volume":"23","author":"Dudova","year":"2022","journal-title":"BMC Genomics"},{"key":"ref242","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1158\/0008-5472.CAN-17-0582","article-title":"PDX-MI: minimal information for patient-derived tumor xenograft models","volume":"77","author":"Meehan","year":"2017","journal-title":"Cancer Res"},{"key":"ref243","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3390\/cancers11101520","article-title":"Integrated biobanking and tumor model establishment of human colorectal carcinoma provides excellent tools for preclinical research","volume":"11","author":"Mullins","year":"2019","journal-title":"Cancers"},{"key":"ref244","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1158\/0008-5472.CAN-19-1166","article-title":"A comprehensive PDX gastric cancer collection captures cancer cell-intrinsic transcriptional MSI traits","volume":"79","author":"Corso","year":"2019","journal-title":"Cancer Res"},{"key":"ref245","doi-asserted-by":"crossref","first-page":"D1073","DOI":"10.1093\/nar\/gky984","article-title":"PDX Finder: a portal for patient-derived tumor xenograft model discovery","volume":"47","author":"Conte","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"ref246","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12943-025-02281-2","article-title":"3D tumor cultures for drug resistance and screening development in clinical applications","volume":"24","author":"Peng","year":"2025","journal-title":"Mol Cancer"},{"key":"ref247","doi-asserted-by":"crossref","first-page":"22294","DOI":"10.1038\/s41598-020-79448-y","article-title":"Scaffold-based 3D cellular models mimicking the heterogeneity of osteosarcoma stem cell niche","volume":"10","author":"Bassi","year":"2020","journal-title":"Sci Rep"},{"key":"ref248","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ijbiomac.2020.12.161","article-title":"Alginate-based hydrogels for cancer therapy and research","volume":"170","author":"Reig-Vano","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"ref249","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/1574888X13666180912142028","article-title":"Chitosan in biomedical engineering: a critical review","volume":"14","author":"Mohebbi","year":"2019","journal-title":"Current Stem Cell Res Therapy"},{"key":"ref250","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2174\/2211738511666230501202946","volume":"11","author":"Abdollahzadeh","year":"2023","journal-title":"Pharm Nanotechnol"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3390\/polym11050916","article-title":"PLA electrospun scaffolds for three-dimensional triple-negative breast cancer cell culture","volume":"11","author":"Polonio-Alcala","year":"2019","journal-title":"Polymers"},{"key":"ref252","doi-asserted-by":"crossref","first-page":"e75345","DOI":"10.1371\/journal.pone.0075345","article-title":"A 3D fibrous scaffold inducing tumoroids: a platform for anticancer drug development","volume":"8","author":"Girard","year":"2013","journal-title":"PLoS One"},{"key":"ref253","doi-asserted-by":"crossref","first-page":"e2300029","DOI":"10.1002\/adbi.202300029","article-title":"Primary glial cell and glioblastoma morphology in cocultures depends on scaffold design and hydrogel composition","volume":"7","author":"Andrade Mier","year":"2023","journal-title":"Adv Biol"},{"key":"ref254","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bbrc.2013.03.008","article-title":"A multicellular 3D heterospheroid model of liver tumor and stromal cells in collagen gel for anti-cancer drug testing","volume":"433","author":"Yip","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"ref255","first-page":"e61606","article-title":"A biomimetic model for liver cancer to study tumor-stroma interactions in a 3D environment with tunable bio-physical properties","volume":"162","author":"Calitz","year":"2020","journal-title":"J Vis Exp"},{"key":"ref256","doi-asserted-by":"crossref","first-page":"947823","DOI":"10.3389\/fonc.2022.947823","volume":"12","author":"Ceccato","year":"2022","journal-title":"Front Oncol"},{"key":"ref257","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00418-022-02172-3","article-title":"Alpha-1 antitrypsin expression is upregulated in multidrug-resistant cancer cells","volume":"159","author":"Divac Rankov","year":"2023","journal-title":"Histochem Cell Biol"},{"key":"ref258","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1021\/acsmedchemlett.0c00076","article-title":"Characterization of an alginate encapsulated LS180 spheroid model for anti-colorectal cancer compound screening","volume":"11","author":"Smit","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"ref259","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11033-019-05111-z","article-title":"Development and verification of a three-dimensional (3D) breast cancer tumor model composed of circulating tumor cell (CTC) subsets","volume":"47","author":"Anil-Inevi","year":"2020","journal-title":"Mol Biol Rep"},{"key":"ref260","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/jbm.a.37121","volume":"109","author":"Rezakhani","year":"2021","journal-title":"J Biomed Mater Res A"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"617141","DOI":"10.3389\/fbioe.2021.617141","article-title":"Design challenges in polymeric scaffolds for tissue engineering","volume":"9","author":"Echeverria Molina","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"key":"ref262","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.yexcr.2013.03.035","article-title":"The role of 3D microenvironmental organization in MCF-7 epithelial-mesenchymal transition after 7 culture days","volume":"319","author":"Foroni","year":"2013","journal-title":"Exp Cell Res"},{"key":"ref263","doi-asserted-by":"crossref","first-page":"e0217640","DOI":"10.1371\/journal.pone.0217640","article-title":"Scaffold-based lung tumor culture on porous PLGA microparticle substrates","volume":"14","author":"Kuriakose","year":"2019","journal-title":"PLoS One"},{"key":"ref264","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.3390\/cancers13143550","article-title":"Multi-layer nanofibrous PCL scaffold-based colon cancer cell cultures to mimic hypoxic tumor microenvironment for bioassay","volume":"13","author":"Oh","year":"2021","journal-title":"Cancers"},{"key":"ref265","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.3390\/ijms21114128","article-title":"Co-culturing of endothelial and cancer cells in a nanofibrous scaffold-based two-layer system","volume":"21","author":"Oh","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref266","doi-asserted-by":"crossref","first-page":"e2200690","DOI":"10.1002\/adhm.202200690","article-title":"Advances in 3D bioprinting for cancer biology and precision medicine: from matrix design to application","volume":"11","author":"Jung","year":"2022","journal-title":"Adv Healthc Mater"},{"key":"ref267","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/s41422-020-0338-1","article-title":"Three-dimensional bioprinted glioblastoma microenvironments model cellular dependencies and immune interactions","volume":"30","author":"Tang","year":"2020","journal-title":"Cell Res"},{"key":"ref268","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jbm.a.37082","article-title":"3D bioprinted glioma microenvironment for glioma vascularization","volume":"109","author":"Wang","year":"2021","journal-title":"J Biomed Mater Res A"},{"key":"ref269","doi-asserted-by":"crossref","first-page":"e1806590","DOI":"10.1002\/adma.201806590","article-title":"3D-bioprinted mini-brain: a glioblastoma model to study cellular interactions and therapeutics","volume":"31","author":"Heinrich","year":"2019","journal-title":"Adv Mater Weinheim"},{"key":"ref270","doi-asserted-by":"crossref","first-page":"044102","DOI":"10.1088\/1758-5090\/aadbde","article-title":"TGF-beta induced epithelial-mesenchymal transition in an advanced cervical tumor model by 3D printing","volume":"10","author":"Pang","year":"2018","journal-title":"Biofabrication"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"120416","DOI":"10.1016\/j.biomaterials.2020.120416","article-title":"Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine","volume":"265","author":"Xie","year":"2021","journal-title":"Biomaterials"},{"key":"ref272","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3389\/fonc.2020.00878","article-title":"Application of a 3D bioprinted hepatocellular carcinoma cell model in antitumor drug research","volume":"10","author":"Sun","year":"2020","journal-title":"Front Oncol"},{"key":"ref273","doi-asserted-by":"crossref","first-page":"034102","DOI":"10.1088\/1758-5090\/ac6127","volume":"14","author":"Han","year":"2022","journal-title":"Biofabrication"},{"key":"ref274","doi-asserted-by":"crossref","first-page":"045014","DOI":"10.1088\/1758-5090\/aba0c3","volume":"12","author":"Mao","year":"2020","journal-title":"Biofabrication"},{"key":"ref275","first-page":"574","article-title":"Advanced development of primary pancreatic organoid tumor models for high-throughput phenotypic drug screening","volume":"23","author":"Hou","year":"2018","journal-title":"SLAS Discov Adv Life Sci RD"},{"key":"ref276","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fbioe.2020.00082","article-title":"Thermal bioprinting causes ample alterations of expression of LUCAT1, IL6, CCL26, and NRN1L genes and massive phosphorylation of critical oncogenic drug resistance pathways in breast cancer cell","volume":"8","author":"Campbell","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"ref277","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/adhm.201500677","article-title":"Controlling shear stress in 3D bioprinting is a key factor to balance printing resolution and stem cell integrity","volume":"5","author":"Blaeser","year":"2016","journal-title":"Adv Healthc Mater"},{"key":"ref278","doi-asserted-by":"crossref","first-page":"044107","DOI":"10.1088\/1758-5090\/aa8dd8","article-title":"Proposal to assess printability of bioinks for extrusion-based bioprinting and evaluation of rheological properties governing bioprintability","volume":"9","author":"Paxton","year":"2017","journal-title":"Biofabrication"},{"key":"ref279","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.biomaterials.2013.09.078","article-title":"The 3D printing of gelatin methacrylamide cell-laden tissue-engineered constructs with high cell viability","volume":"35","author":"Billiet","year":"2014","journal-title":"Biomaterials"},{"key":"ref280","doi-asserted-by":"crossref","first-page":"041319","DOI":"10.1063\/5.0023206","article-title":"Biomechanical factors in three-dimensional tissue bioprinting","volume":"7","author":"Ning","year":"2020","journal-title":"Appl Phys Rev"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nbt.2958","article-title":"3D bioprinting of tissues and organs","volume":"32","author":"Murphy","year":"2014","journal-title":"Nat Biotechnol"},{"key":"ref282","doi-asserted-by":"crossref","first-page":"26859","DOI":"10.1021\/acsami.8b06607","article-title":"Visible light photoinitiation of cell-adhesive gelatin methacryloyl hydrogels for stereolithography 3D bioprinting","volume":"10","author":"Wang","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref283","first-page":"356","article-title":"Embedded 3D bioprinting\u2014an emerging strategy to fabricate biomimetic & large vascularized tissue constructs","volume":"32","author":"Budharaju","year":"2024","journal-title":"Bioact Mater"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.techscience.cn\/files\/or\/2025\/TSP_OR-33-10\/OncolRes-33-10-67126\/OncolRes-33-67126.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:20:32Z","timestamp":1763346032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n10\/63888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":283,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2025.067126","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}